Article Abstract
Questions about the efficacy of antidepressantdrugs in depression have beenraised as a result of 2 recent reports.Turner et al. reviewed industry-sponsoredclinical trials (randomized controlled trials;RCTs) submitted to the FDA and foundthat positive RCTs were more likely to besubsequently published than negative trials.The authors suggested that publisheddata overestimate the effectiveness of antidepressants.
From the Editors
Are you a healthcare provider?
Add your NPI to personalize your JCP experience.
Buy PDF for $40.00
Please sign in or purchase this PDF for $40.00.
